The fate of patients with intermittent claudication in the 21st century revisited-results from the CAVASIC Study

Scientific Reports

Volumn 8, Issue , 2017, Pages

  Rantner, Barbara ^a   Kollerits, Barbara ^a   Pohlhammer, Johannes ^a   Stadler, Marietta ^b,c   Lamina, Claudia ^a   Peric, Slobodan ^b   Klein Weigel, Peter ^d   Mühlthaler, Hannes ^a,e   Fraedrich, Gustav ^a   Kronenberg, Florian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b HIETZING HOSPITAL   (Austria)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HELIOS KLINIKUM BERLIN BUCH   (Germany)

^e Clinic for Surgery Ophthalmology and Dentistry   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COMPLICATION; CORONARY ARTERY DISEASE; HUMAN; INTERMITTENT CLAUDICATION; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR; TIME FACTOR;

AGED; CORONARY ARTERY DISEASE; HUMANS; INTERMITTENT CLAUDICATION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; TIME FACTORS;

EID: 85016713539     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45833     Document Type: Article

References (30)

1. Newman, A. B. et al. Ankle-Arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler. Thromb. Vasc. Biol. 19, 538-545 (1999).
2. Resnick, H. E. et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The Strong Heart Study. Circulation 109, 733-739 (2004).
3. Begg, T. B. & Richards, R. L. The prognosis of intermittent claudication. Scott. Med. J. 7, 341-352 (1962).
4. Juergens, J. L., Barker, N. W. & Hines, E. A. Jr. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 21, 188-195 (1960).
5. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section B: intermittent claudication. Eur. J. Vasc. Endovasc. Surg. 19 Suppl A, S47-114 (2000).
6. Norgren, L. et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J. Vasc. Surg. 45 Suppl S, S5-67 (2007).
7. Hirsch, A. T. et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113, e463-e654 (2006).
8. Rantner, B. et al. Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC Study. Clin. Chem. 54, 851-857 (2008).
9. Kollerits, B. et al. Comparison and evaluation of cardiac biomarkers in patients with intermittent claudication: Results from the CAVASIC Study. Clin. Chem. 59, 692-702 (2013).
10. Raschenberger, J. et al. The association of relative telomere length with symptomatic peripheral arterial disease: Results from the CAVASIC Study. Atherosclerosis 229, 469-474 (2013).
11. Pohlhammer, J. et al. High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortal. Atherosclerosis 237, 711-717 (2014).
12. Rantner, B. et al. Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication-results from the CAVASIC Study. Atherosclerosis 239, 428-435 (2015).
13. Schröder, F. et al. A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of peripheral arterial disease. J Vasc. Surg. 44, 531-536 (2006).
14. Ohman, E. M. et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J 151, 786-10 (2006).
15. Leng, G. C. & Fowkes, F. G. The Edinburgh Claudication Questionnaire: An improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J. Clin. Epidemiol. 45, 1101-1109 (1992).
16. Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604-612 (2009).
17. Bainton, D., Sweetnam, P., Baker, I. & Elwood, P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br. Heart J. 72, 128-132 (1994).
18. Criqui, M. H. et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N. Engl. J. Med. 326, 381-386 (1992).
19. Smith, G. D., Shipley, M. J. & Rose, G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 82, 1925-1931 (1990).
20. van Lammeren, G. W. et al. Time-dependent changes in atherosclerotic plaque composition in patients undergoing carotid surgery. Circulation 129, 2269-2276 (2014).
21. Menotti, A., Lanti, M. & Puddu, P. E. Twenty-five-year cardiovascular disease incidence among middle-Aged men. Disease burden, time shape, predictors, risk probabilities. Ital. Heart J. 1, 749-757 (2000).
22. Lamina, C. et al. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13-years of follow-up. Eur. Heart J. 27, 2580-2587 (2006).
23. Fiotti, N. et al. Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. Eur. J. Vasc. Endovasc. Surg. 26, 374-380 (2003).
24. Taute, B. M., Thommes, S., Taute, R. & Podhaisky, H. The possible risk of cancer in claudicants. Angiology 62, 579-584 (2011).
25. Onega, T. et al. Cancer risk and subsequent survival after hospitalization for intermittent claudication. Cancer Epidemiol. Biomarkers Prev. 24, 744-748 (2015).
26. Puddu, P. E. & Menotti, A. Natural history of coronary heart disease and heart disease of uncertain etiology: Findings from a 50-year population study. Int. J. Cardiol. 197, 260-264 (2015).
27. Puddu, P. E., Piras, P. & Menotti, A. Lifetime competing risks between coronary heart disease mortality and other causes of death during 50years of follow-up. Int. J. Cardiol. 228, 359-363 (2017).
28. Zeymer, U. et al. Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort. Clin. Res. Cardiol. 98, 249-256 (2009).
29. Weitz, J. I. et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation 94, 3026-3049 (1996).
30. Farkouh, M. E. et al. Influence of coronary heart disease on morbidity and mortality after lower extremity revascularization surgery: A population-based study in Olmsted County, Minnesota (1970-1987). J. Am. Coll. Cardiol. 24, 1290-1296 (1994).